首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1348231

神經修復術：各種技術與全球市場

Neuroprosthetics: Technologies and Global Markets

出版日期: 2023年09月13日 | 出版商:

BCC Research | 英文 168 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球神經修復市場規模預計將從2022年的50億美元和2023年的54億美元成長到2028年的81億美元，預測期內年複合成長率為8.3%。

按產品類型分類，人工耳蝸部門預計將從2022年的 15 億美元成長到2023年的 16 億美元，年複合成長率為 5.2%，到2028年將成長到 21 億美元。此外，膀胱和腸道控制植入物部門預計將從2022年的 9.677 億美元和2023年的 11 億美元成長到2028年的 19 億美元，年複合成長率為 11.6%。我是。

本報告調查了全球神經義肢市場，並提供了市場和技術概述，市場影響因素分析，法律制度，市場規模趨勢和預測，各個細分市場和地區的詳細分析以及技術和專利趨勢，ESG發展，競爭形勢，主要企業簡介等。

市場概況
人工耳蝸
DBS
DBS 的已透過核准適應症
膀胱/腸道控制植入物
薦神經刺激設備（SNS）
脛神經刺激設備(TNS)
用於運動恢復的神經假體
功能性電刺激（FES）
腦機介面（BCI）
神經控制義肢
肌電義肢
大腦控制的義肢
BCI技術在義肢的應用現狀
其他
人工視覺/人工視網膜
隔膜起搏系統/橫膈神經刺激設備
市場收入：依產品類型分類
人工耳蝸
人工耳蝸：按地區分類的收入
深層腦部刺激器(DBS)
星展銀行：按地區分類的收入
用於運動恢復的神經假體
用於運動恢復的神經假體：按地區分類的收入
膀胱/腸道控制植入物
膀胱和腸道控制植入物：按地區分類的收入
其他
其他：按地區分類的收入

第6章市場細分：依用途

市場概況
神經系統功能的替代
神經系統的調節
市場收入：依用途
神經系統功能的替代
市場收入：按地區
神經系統的調節
市場收入：按地區

第7章市場細分：依地區

市場概況
市場收入：按地區
北美洲
歐洲
亞太地區
其他地區

第8章 ESG發展

ESG：簡介
神經修復產業的永續性：ESG觀點
主要 ESG 議題
產業ESG績效分析
BCC的結語

第9章新興技術和發展

概述
大腦控制的義肢
帶感官的義肢
使用人工智慧的神經修復術
網路化神經假體系統
小型設備和無線連接和電源

第10章臨床試驗

概述
人工耳蝸
用於運動恢復的神經假體
腦機介面（BCI）
功能性電刺激（FES）
深層腦部刺激器(DBS)
膀胱/腸道控制植入物
其他

第11章競爭資訊

概述
人工耳蝸
公司市佔率
市場領導者產品系列
深層腦部刺激器(DBS)
公司市佔率
市場領導者產品系列
膀胱/腸道控制植入物
公司市佔率
市場領導者產品系列
用於運動恢復的神經假體
主要企業產品系列
其他
M&A

第12章公司簡介

ABBOTT LABORATORIES
AXONICS INC.
BIOVENTUS
BLACKROCK NEUROTECH
BOSTON SCIENTIFIC CORP.
COCHLEAR LTD.
CYBERDYNE INC.
MED-EL MEDICAL ELECTRONICS
MEDTRONIC
NEUROPACE INC.
PARADROMICS
SONOVA
SYNCHRON
VIVANI MEDICAL INC.

第13章附錄

簡介目錄圖表

Product Code: MDS098A

Highlights:

The global neuroprosthetics market reached $5.0 billion in 2022, should reach $5.4 billion by 2023 and $8.1 billion by 2028 with a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2023-2028.

Cochlear implants segment of the global neuroprosthetics market reached $1.5 billion in 2022, should reach $1.6 billion by 2023 and $2.1 billion by 2028 with a CAGR of 5.2% during the forecast period of 2023-2028.

Bladder and bowel control implants segment of the global neuroprosthetics market reached $967.7 million in 2022, should reach $1.1 billion by 2023 and $1.9 billion by 2028 with a CAGR of 11.6% during the forecast period of 2023-2028.

Report Scope:

This research study aims to thoroughly assess and analyze the neuroprosthetics market, revenue forecasts and future trends, globally, and to provide strategic recommendations for the success of market participants. The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type, application and region from 2023 through 2028.

This report also includes an analysis of leading and emerging competitors in the worldwide neuroprosthetics market. Profiles of leading product manufacturers and emerging players with novel products in development are also analyzed. This report assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.

Report Includes:

32 data tables and 49 additional tables
A comprehensive overview and an up-to-date analysis of the global market for Neuroprosthetics
Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
Estimation of the actual market size and revenue forecast for global neuroprosthetics market in USD million values, and corresponding market share analysis based on product, type of stimulation technology, application, and region
In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, future prospects, and contributions to the overall market
Discussion of ESG developments in Neuroprosthetics market, and an understanding of the importance of ESG, consumer attitudes towards sustainability, risks and opportunity assessment, and ESG followed practices by product manufacturers and industry participants
A relevant patent analysis with significant allotments of key patent grants on Neuroprosthetics
Review of the recent merger and acquisition (M&A) activities, venture fundings, and other impactful strategies contributing to the growth of this market
Identification of leading and emerging competitors in the worldwide neuroprosthetics market, and analysis of competitive landscape based on recent developments, segmental revenues, and operational integration
Company profiles of major players within the industry, including Abbott Laboratories, Boston Scientific Corp., Cochlear Ltd., Medtronic, and Sonova

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology and Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Market Summary

Chapter 3 Market Overview

Overview and Definitions
Neuroprosthetics
Need for Neuroprosthetics
Types of Neuroprosthetics
Cochlear Implants
Neuroprosthetics for Movement Restoration
Deep Brain Stimulators (DBS)
Bladder and Bowel Control Implants
Visual Prosthetics
Regulatory Landscape
U.S.
Europe

Chapter 4 Market Dynamics

Drivers
Favorable Demographic Trends
Technological Advancements
Support from Regulatory Agencies
Increasing Pressure to Cut Costs
Robust Funding Environment for Biomedical Research
Unpenetrated Market
Challenges
High Cost
Technological Challenges
Safety Concerns
Privacy and Accountability Concerns
Inconsistent Reimbursement Policies
Key Factors Impacting Market

Chapter 5 Market Breakdown by Product Type

Market Overview
Cochlear Implants
Deep Brain Stimulators
Approved Indications for Deep Brain Stimulation Therapy
Bladder and Bowel Control Implants
Sacral Nerve Stimulators (SNSs)
Tibial Nerve Stimulators (TNSs)
Neuroprosthetics for Movement Restoration
Neuroprosthetics for Movement Restoration
Functional Electrical Stimulation (FES)
Brain/Computer Interface (BCI)
Neural-controlled Prosthetic Limbs
Myoelectric Prostheses
Brain-controlled Prosthetic Limbs
Current State of BCI Technology in Prosthetics
Others
Visual Prosthetics/Retinal Prosthetics
Diaphragm Pacing System/Phrenic Nerve Stimulator
Market Revenue by Product Type
Cochlear Implants
Cochlear Implants Market Revenue by Region
Deep Brain Stimulators (DBS)
DBS Market Revenue by Region
Neuroprosthetics for Movement Restoration
Neuroprosthetics for Movement Restoration Market Revenue by Region
Bladder and Bowel Control Implants
Bladder and Bowel Control Implants: Market Revenue by Region
Others
Others Market Revenue by Region

Chapter 6 Market Breakdown by Application

Market Overview
Nervous System Function Replacement
Nervous System Modulation
Market Revenue by Application
Nervous System Function Replacement
Market Revenue by Region
Nervous System Modulation
Market Revenue by Region

Chapter 7 Market Breakdown by Region

Market Overview
Market Revenue by Region
North America
Reimbursement and Insurance Coverage
Innovation Hub and Robust Funding
Encouraging Regulatory Environment
Market Demand and Adoption
Market Revenue by Product Type
Market Revenue by Application
Market Revenue by Country
Europe
Market Revenue by Product Type
Market Revenue by Application
Market Revenue by Country
Asia-Pacific
Market Revenue by Product Type
Market Revenue by Application
Market Revenue by Country
Rest of the World (RoW)
Market Revenue by Product Type
Market Revenue by Application

Chapter 8 ESG Development

Introduction to ESG
Sustainability in the Neuroprosthetics Industry: An ESG Perspective
Key ESG Issues
Industry ESG Performance Analysis
Concluding Remarks from BCC

Chapter 9 Emerging Technologies and Development

Overview
Brain Controlled Prosthetics
Prosthesis with Sensations
Artificial Intelligence (AI) Powered Neuroprosthetics
Networked Neuroprosthesis System
Miniaturized Devices and Wireless Connectivity and Powering

Chapter 10 Clinical Trials

Overview
Cochlear Implants
Neuroprosthetics for Movement Restoration
Brain Computer Interface (BCI)
Functional Electrical Stimulation (FES)
Deep Brain Stimulators (DBS)
Bladder and Bowel Control Implants
Others

Chapter 11 Competitive Intelligence

Overview
Cochlear Implants
Company Market Shares
Market Leader Product Portfolio
Deep Brain Stimulators (DBS)
Company Market Shares
Market Leader Product Portfolio
Bladder and Bowel Control Implants
Company Market Shares
Market Leader Product Portfolio
Neuroprosthetics for Movement Restoration
Key Companies Product Portfolio
Others
Mergers and Acquisitions (M&A)

Chapter 12 Company Profiles

ABBOTT LABORATORIES
AXONICS INC.
BIOVENTUS
BLACKROCK NEUROTECH
BOSTON SCIENTIFIC CORP.
COCHLEAR LTD.
CYBERDYNE INC.
MED-EL MEDICAL ELECTRONICS
MEDTRONIC
NEUROPACE INC.
PARADROMICS
SONOVA
SYNCHRON
VIVANI MEDICAL INC.

Chapter 13 Appendix

簡介目錄圖表

List of Tables

Summary Table : Global Market for Neuroprosthetics, by Product Type, Through 2028
Table 1 : Impairments Due to Dysfunction or Damaged Neurons
Table 2 : U.S. FDA Device Classification of Neuroprosthetics
Table 3 : Public Agency Funding/Initiatives, Neuroprosthetic Advancements
Table 4 : Funds Raised, by Selected BCI Companies
Table 5 : Factors Impacting Neuroprosthetics Market
Table 6 : BCI Signal Acquisition Technologies
Table 7 : BCI Industry Overview
Table 8 : Motor Impairments and Prevalence
Table 9 : Sensory Impairments and Prevalence
Table 10 : Global Market for Neuroprosthetics, by Product Type, Through 2028
Table 11 : Global Hearing Loss Prevalence, by WHO Region, 2019
Table 12 : Global Market for Cochlear Implants, by Region, Through 2028
Table 13 : Global Market for DBS, by Region, Through 2028
Table 14 : Global Market for Neuroprosthetics for Movement Restoration, by Region, Through 2028
Table 15 : Global Market for Bladder and Bowel Control Implants, by Region, Through 2028
Table 16 : Global Market for Other Neuroprosthetics, by Region, Through 2028
Table 17 : Global Market for Neuroprosthetics, by Application, Through 2028
Table 18 : Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, Through 2028
Table 19 : Global Market for Neuroprosthetics for Nervous System Modulation, by Region, Through 2028
Table 20 : Global Market for Neuroprosthetics, by Region, Through 2028
Table 21 : North American Market for Neuroprosthetics, by Product Type, Through 2028
Table 22 : North American Market for Neuroprosthetics, by Application, Through 2028
Table 23 : North American Market for Neuroprosthetics, by Country, Through 2028
Table 24 : European Market for Neuroprosthetics, by Product Type, Through 2028
Table 25 : European Market for Neuroprosthetics, by Application, Through 2028
Table 26 : European Market for Neuroprosthetics, by Country, Through 2028
Table 27 : Asia-Pacific Market for Neuroprosthetics, by Product Type, Through 2028
Table 28 : Asia-Pacific Market for Neuroprosthetics, by Application, Through 2028
Table 29 : Asia-Pacific Market for Neuroprosthetics, by Country, Through 2028
Table 30 : RoW Market for Neuroprosthetics, by Product Type, Through 2028
Table 31 : RoW Market for Neuroprosthetics, by Application, Through 2028
Table 32 : Critical ESG Factors in Neuroprosthetics
Table 33 : Major Neuroprosthetics Achievements: Key ESG Focus Areas
Table 34 : ESG Rankings of Major Neuroprosthetics Companies, 2023*
Table 35 : CDP Scope Card for Major Neuroprosthetics Companies, 2022
Table 36 : Selected Significant Developments in BCI Technology
Table 37 : Selected Cochlear Implants in Clinical Trial
Table 38 : Selected BCI Neuroprosthetics in Clinical Trial
Table 39 : Selected FES Neuroprosthetics in Clinical Trial
Table 40 : Selected DBS in Clinical Trial
Table 41 : Selected Bladder and Bowel Control Implants in Development
Table 42 : Selected Visual Prosthetics in Development
Table 43 : Market Leader Cochlear Implants Product Portfolio
Table 44 : Currently Available: Deep Brain Stimulators (DBSs)
Table 45 : Currently Available: Bladder and Bowel Control Implants
Table 46 : Selected Neuroprosthetics for Movement Restoration
Table 47 : Currently Available Diaphragm Pacing System
Table 48 : M&A in the Neuroprosthetics Market Jan. 2021-May 2023
Table 49 : Abbott Laboratories: Financials, 2022
Table 50 : Abbott Laboratories: Neuroprosthetics Portfolio
Table 51 : Abbott Laboratories: News/Key Developments, Jan 2021-June 2023
Table 52 : Axonics Inc.: Financials, 2022
Table 53 : Axonics Inc.: Neuroprosthetics Portfolio
Table 54 : Axonics Inc.: News/Key Developments, Jan. 2022-June 2023
Table 55 : Bioventus: Financials, 2022
Table 56 : Bioventus: Neural Prosthetics Portfolio
Table 57 : Bioventus: News/Key Developments, Jan. 2021-June 2023
Table 58 : Blackrock Neurotech: Product Portfolio
Table 59 : Blackrock Neurotech: News/Key Developments, Jan. 2021-June 2023
Table 60 : Boston Scientific Corp.: Financials, 2022
Table 61 : Boston Scientific Corp.: Neuroprosthetics Portfolio
Table 62 : Boston Scientific Corp.: News/Key Developments, Jan. 2021-June 2023
Table 63 : Cochlear Ltd.: Financials, 2022
Table 64 : Cochlear Ltd.: Neural Prosthetics Portfolio
Table 65 : Cochlear Ltd.: News/Key Developments, Jan. 2021-June 2023
Table 66 : Cyberdyne Inc.: Financials, 2022*
Table 67 : Cyberdyne Inc.: Neural Prosthetics Portfolio
Table 68 : MED EL: Neuroprosthetics Portfolio
Table 69 : Medtronic: Financials, 2022
Table 70 : Medtronic: Neuroprosthetics Portfolio
Table 71 : Medtronic: News/Key Developments, Jan. 2021-June 2023
Table 72 : NeuroPace Inc.: Financials, 2022
Table 73 : NeuroPace Inc.: Neuroprosthetic Portfolio
Table 74 : NeuroPace Inc.: News/Key Developments, Jan. 2018-June 2023
Table 75 : Paradromics: News/Key Developments, Dec. 2020-June 2023
Table 76 : Sonova: Financials, 2022
Table 77 : Sonova: Neural Prosthetics Portfolio
Table 78 : Sonova: News/Key Developments, Dec. 2020-June 2023
Table 79 : Synchron: News/Key Developments, Jan. 2020-June 2023
Table 80 : Acronyms

List of Figures

Summary Figure A : Global Market for Neuroprosthetics, by Product Type, 2020-2028
Summary Figure B : Global Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 1 : Percentage of Disability, Adults 18+, U.S., 2019
Figure 2 : Granted Breakthrough Device Designations (BDD), by Clinical Panel, As of March 31, 2023
Figure 3 : DBS Primary Treatment: Patient Shares, by Indication
Figure 4 : Leading Cause of Paralysis
Figure 5 : Stroke and Associated Burden on Healthcare System in U.S., Europe and Canada
Figure 6 : BCI Device Steps
Figure 7 : BCI Signal Acquisition Technologies, by Type
Figure 8 : Advantages of Brain-Controlled Prosthetic Limbs
Figure 9 : Global Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 10 : Global Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 11 : Hearing Loss Prevalence, by Age Group, 2019
Figure 12 : Global Market for Cochlear Implants, by Region, 2020-2028
Figure 13 : Global Market Shares of Cochlear Implants, by Region, 2022
Figure 14 : Global Market for DBS, by Region, 2020-2028
Figure 15 : Global Market Shares of DBS, by Region, 2022
Figure 16 : Global Market for Neuroprosthetics for Movement Restoration, by Region, 2020-2028
Figure 17 : Global Market Shares of Neuroprosthetics for Movement Restoration, by Region, 2022
Figure 18 : Global Market for Bladder and Bowel Control Implants, by Region, 2020-2028
Figure 19 : Global Market Shares of Bladder and Bowel Control Implants, by Region, 2022
Figure 20 : Global Market for Other Neuroprosthetics, by Region, 2020-2028
Figure 21 : Global Market Shares of Other Neuroprosthetics, by Region, 2022
Figure 22 : Global Market for Neuroprosthetics, by Application, 2020-2028
Figure 23 : Global Market Shares of Neuroprosthetics, by Application, 2022
Figure 24 : Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, 2020-2028
Figure 25 : Global Market Shares of Neuroprosthetics for Nervous System Function Replacement, by Region, 2022
Figure 26 : Global Market for Neuroprosthetics for Nervous System Modulation, by Region, 2020-2028
Figure 27 : Global Market Shares of Neuroprosthetics for Nervous System Modulation, by Region, 2022
Figure 28 : Global Market for Neuroprosthetics, by Region, 2020-2028
Figure 29 : Global Market Shares of Neuroprosthetics, by Region, 2022
Figure 30 : Investment on Grants for Biomedical Research, by Region, in 2020
Figure 31 : North American Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 32 : North American Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 33 : North American Market for Neuroprosthetics, by Application, 2020-2028
Figure 34 : North American Market Shares of Neuroprosthetics, by Application, 2022
Figure 35 : North American Market for Neuroprosthetics, by Country, 2020-2028
Figure 36 : European Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 37 : European Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 38 : European Market for Neuroprosthetics, by Application, 2020-2028
Figure 39 : European Market Shares of Neuroprosthetics, by Application, 2022
Figure 40 : European Market for Neuroprosthetics, by Country, 2020-2028
Figure 41 : Global Aging (60+) Population, by Region, 2015-2050
Figure 42 : Asia-Pacific Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 43 : Asia-Pacific Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 44 : Asia-Pacific Market for Neuroprosthetics, by Application, 2020-2028
Figure 45 : Asia-Pacific Market Shares of Neuroprosthetics, by Application, 2022
Figure 46 : Asia-Pacific Market for Neuroprosthetics, by Country, 2020-2028
Figure 47 : RoW Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 48 : RoW Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 49 : RoW Market for Neuroprosthetics, by Application, 2020-2028
Figure 50 : RoW Market Shares of Neuroprosthetics, by Application, 2022
Figure 51 : Selected Factors Driving ESG
Figure 52 : How A Strong ESG Proposition Benefits Business
Figure 53 : Five Key ESG Focus Areas, Neuroprosthetics, 2022
Figure 54 : Emerging Trends/Technologies in the Neuroprosthetics Market
Figure 55 : Advantages of The Networked Neuroprosthetic (NNP) System
Figure 56 : Principle Competitive Factors in the Neuroprosthetics Market
Figure 57 : Global Market Shares of Cochlear Implants, by Manufacturer, 2022
Figure 58 : Global Market Shares of DBS, by Manufacturer, 2022
Figure 59 : Global Market Shares of Bladder and Bowel Control Implants, by Manufacturer, 2022
Figure 60 : Abbott Laboratories: Financials, 2021 and 2022
Figure 61 : Abbott Laboratories: Revenue Shares, by Business Unit, 2022
Figure 62 : Abbott Laboratories: Revenue Shares, by Region, 2022
Figure 63 : Axonics Inc.: Financials, 2021 and 2022
Figure 64 : Axonics Inc.: Revenue Shares, by Product, 2022
Figure 65 : Axonics Inc.: Revenue Shares, by Region, 2022
Figure 66 : Bioventus: Financials, 2021 and 2022
Figure 67 : Bioventus: Revenue Shares, by Business Unit, 2022
Figure 68 : Bioventus: Revenue Shares, by Region, 2022
Figure 69 : Boston Scientific Corp.: Financials, 2021 and 2022
Figure 70 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 71 : Boston Scientific Corp.: Revenue Shares, by Region, 2022
Figure 72 : Cochlear Ltd.: Financials, 2021 and 2022
Figure 73 : Cochlear Ltd.: Revenue Shares, by Business Segment, 2022
Figure 74 : Cochlear Ltd.: Revenue Shares, by Region, 2022
Figure 75 : Cyberdyne Inc.: Financials, 2021 and 2022
Figure 76 : Cyberdyne Inc.: Revenue Shares, by Business Type, 2022
Figure 77 : Cyberdyne Inc.: Revenue Shares, by Region, 2022
Figure 78 : Medtronic: Financials, 2021 and 2022
Figure 79 : Medtronic: Revenue Shares, by Business Unit, 2022
Figure 80 : Medtronic: Revenue Shares, by Region, 2022
Figure 81 : NeuroPace Inc.: Financials, 2021 and 2022
Figure 82 : Sonova: Financials, 2021 and 2022
Figure 83 : Sonova: Revenue Shares, by Business Unit, 2022
Figure 84 : Sonova: Revenue Shares, by Region, 2022